市场调查报告书
商品编码
1368721
蛋白质纯化与分离市场技术[製备层析、(亲和、离子交换)、超滤]、产品[消耗品(试剂盒、试剂)、仪器]、应用、最终用户、2023 - 2032 年全球预测Protein Purification & Isolation Market-Technology [Preparative Chromatography, (Affinity, Ion Exchange), Ultrafiltration], Product [Consumable (Kit, Reagent), Instrument], Application, End-user, Global Forecast 2023 - 2032 |
在色谱、电泳和过滤技术不断进步的推动下,蛋白质纯化和分离市场规模预计从 2023 年到 2032 年将以 10.5% 的复合年增长率扩大。这些技术在分辨率、速度和可扩展性方面的改进能力显着增强了纯化过程,使研究人员和生物製药公司能够分离出用于各种治疗和诊断应用的高品质蛋白质。
包括胰岛素和抗体在内的蛋白质药物的生产速度不断上升,导致对蛋白质纯化的需求更高。持续进行的有助于降低生产成本的研发工作也将支持市场成长。例如,2023 年 2 月,麻省理工学院的工程师设计了一种新的纯化方法,透过部署专门的奈米粒子来快速结晶蛋白质,使发展中国家更容易获得和负担得起蛋白质药物。
蛋白质纯化和分离产业分为技术、产品、应用、最终用户和地区。
就技术而言,到2032 年,超滤领域的市场价值可能会显着增长。这一增长可归因于越来越多地采用该技术,以选择性保留蛋白质,同时消除污染物,从而简化纯化工作流程并确保高产量纯蛋白质。此外,对成本效益、可扩展性和温和操作条件的需求不断增加,使得超滤技术在各种生物製药和研究应用中越来越受到青睐。
在应用方面,药物筛选领域的蛋白质纯化和分离行业在2022 年产生了可观的收入,预计到2032 年将实现强劲增长。对药物发现和开发的日益关注,加上对高质量纯化蛋白质的需求不断成长临床前和临床研究正在推动先进纯化和分离技术的采用。纯化蛋白在理解疾病机制和开发个人化疗法的应用将进一步加速细分市场的扩张。
从地区来看,由于生物製药和生物技术产业的强劲发展,欧洲蛋白质纯化和分离市场预计将在 2023 年至 2032 年期间呈现强劲成长。对研发活动的大量投资以及对个人化医疗和标靶治疗的日益重视正在推动对先进蛋白质纯化和分离技术的需求。此外,完善的医疗基础设施以及对学术研究和产业合作的高度重视将增强该地区的产业前景。
Protein Purification and Isolation Market size is estimated to expand at 10.5% CAGR from 2023-2032 driven by the continual advancements in chromatography, electrophoresis, and filtration technologies. The improved capabilities of these technologies in terms of resolution, speed, and scalability is significantly enhancing the purification process for enabling researchers and biopharmaceutical companies to isolate high-quality proteins for various therapeutic and diagnostic applications.
The rising rate of manufacturing of protein drugs, including insulin and antibodies is leading to the higher need for purification of protein. The ongoing R&D efforts to help reduce the production costs will also support the market growth. For instance, in February 2023, MIT engineers devised a new way to perform purification by deploying specialized nanoparticles to rapidly crystallize proteins for making protein drugs more accessible and affordable in developing countries.
The protein purification & isolation industry is segmented into technology, product, application, end-user, and region.
With respect to technology, the market value from the ultrafiltration segment is likely to gain significant traction through 2032. The growth can be attributed to the growing adoption of this technology to selectively retain proteins while eliminating contaminants for streamlining the purification workflow and ensuring high yields of pure proteins. Additionally, the surging need for cost-effectiveness, scalability, and gentle operating conditions are contributing to the increasing preference for ultrafiltration technology in various biopharmaceutical and research applications.
In terms of application, the protein purification & isolation industry from the drug screening segment generated substantial revenue in 2022 and is projected to record robust growth through 2032. The increasing focus on drug discovery and development coupled with the rising demand for high-quality purified proteins for preclinical and clinical research is propelling the adoption of advanced purification and isolation techniques. The application of purified proteins in understanding disease mechanisms and developing personalized therapeutics will further accelerate the segment expansion.
Regionally, Europe protein purification & isolation market is set to exhibit robust growth from 2023 to 2032 attributed to the presence of robust biopharmaceutical and biotechnology sectors. Massive investments in R&D activities along with the growing emphasis on personalized medicine and targeted therapeutics are fueling the demand for advanced protein purification and isolation technologies. Moreover, the presence of well-established healthcare infrastructure and the strong focus on academic research and industrial collaborations will augment the regional industry outlook.